Back to Search Start Over

Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation.

Authors :
Wang Y
Wei T
Zhao M
Huang A
Sun F
Chen L
Lin R
Xie Y
Zhang M
Xu S
Sun Z
Hong L
Wang R
Tian R
Li G
Source :
PLoS biology [PLoS Biol] 2024 May 20; Vol. 22 (5), pp. e3002550. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Publication Year :
2024

Abstract

Alkenyl oxindoles have been characterized as autophagosome-tethering compounds (ATTECs), which can target mutant huntingtin protein (mHTT) for lysosomal degradation. In order to expand the application of alkenyl oxindoles for targeted protein degradation, we designed and synthesized a series of heterobifunctional compounds by conjugating different alkenyl oxindoles with bromodomain-containing protein 4 (BRD4) inhibitor JQ1. Through structure-activity relationship study, we successfully developed JQ1-alkenyl oxindole conjugates that potently degrade BRD4. Unexpectedly, we found that these molecules degrade BRD4 through the ubiquitin-proteasome system, rather than the autophagy-lysosomal pathway. Using pooled CRISPR interference (CRISPRi) screening, we revealed that JQ1-alkenyl oxindole conjugates recruit the E3 ubiquitin ligase complex CRL4DCAF11 for substrate degradation. Furthermore, we validated the most potent heterobifunctional molecule HL435 as a promising drug-like lead compound to exert antitumor activity both in vitro and in a mouse xenograft tumor model. Our research provides new employable proteolysis targeting chimera (PROTAC) moieties for targeted protein degradation, providing new possibilities for drug discovery.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Details

Language :
English
ISSN :
1545-7885
Volume :
22
Issue :
5
Database :
MEDLINE
Journal :
PLoS biology
Publication Type :
Academic Journal
Accession number :
38768083
Full Text :
https://doi.org/10.1371/journal.pbio.3002550